12/4
01:01 pm
ctxr
Citius Pharmaceuticals (NASDAQ:CTXR) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $6.00 price target on the stock.
Low
Report
Citius Pharmaceuticals (NASDAQ:CTXR) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $6.00 price target on the stock.
11/20
01:33 pm
ctxr
Citius Pharmaceuticals (NASDAQ:CTXR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Citius Pharmaceuticals (NASDAQ:CTXR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/21
04:30 pm
ctxr
Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
Medium
Report
Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
10/21
08:00 am
ctxr
Citius Pharmaceuticals Announces a Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
Medium
Report
Citius Pharmaceuticals Announces a Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
10/17
05:16 pm
ctxr
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences [Yahoo! Finance]
High
Report
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences [Yahoo! Finance]
10/17
05:00 pm
ctxr
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences
High
Report
Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences
9/10
05:10 pm
ctxr
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]
Low
Report
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]